omega-n-methylarginine has been researched along with lithium in 6 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (lithium) | Trials (lithium) | Recent Studies (post-2010) (lithium) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 23,339 | 1,102 | 4,484 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, M; Kanba, S; Kato, R; Nakaki, T; Nakamura, R; Richelson, E; Sato, K; Shintani, F; Yagi, G | 1 |
| Bech, JN; Nielsen, CB; Pedersen, EB | 1 |
| Collins, M; Kerrigan, RJ; Khraibi, AA; Knox, FG; Onsgard-Meyer, MJ | 1 |
| Dijkhorst-Oei, LT; Koomans, HA | 1 |
| Bech, JN; Nielsen, CB; Pedersen, EB; Svendsen, KB | 1 |
| Bech, JN; Nielsen, EH; Pedersen, EB; Pedersen, RS; Svendsen, KB | 1 |
4 trial(s) available for omega-n-methylarginine and lithium
| Article | Year |
|---|---|
Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
Topics: Adult; Blood Pressure; Cyclic GMP; Diuresis; Female; Glomerular Filtration Rate; Heart Rate; Hemodynamics; Hormones; Humans; Lithium; Male; Natriuresis; Nitric Oxide; omega-N-Methylarginine; Potassium; Renal Circulation | 1996 |
Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Diet; Diuresis; Enzyme Inhibitors; Hemodynamics; Humans; Kidney; Lithium; Male; Metabolic Clearance Rate; Natriuresis; Nitric Oxide Synthase; omega-N-Methylarginine; Osmolar Concentration; Reference Values; Renin; Sodium | 1998 |
The systemic and renal response to NO inhibition is not modified by angiotensin-II-receptor blockade in healthy humans.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Lithium; Male; Nitric Oxide; omega-N-Methylarginine; Sodium | 1999 |
Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Topics: Administration, Oral; Adult; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Cyclic GMP; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Lithium; Male; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Renal Circulation; Renin-Angiotensin System; Sodium; Sodium Chloride; Time Factors | 2007 |
2 other study(ies) available for omega-n-methylarginine and lithium
| Article | Year |
|---|---|
Inhibition by lithium of cyclic GMP formation without inhibition of nitric oxide generation in the mouse neuroblastoma cell (N1E-115).
Topics: Animals; Arginine; Brain Neoplasms; Carbachol; Cyclic GMP; Guanylate Cyclase; Lithium; Mice; Muscarinic Antagonists; Neuroblastoma; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Tumor Cells, Cultured | 1994 |
Phosphaturic effect of L-NMMA in the presence of parathyroid hormone.
Topics: Animals; Enzyme Inhibitors; Lithium; Male; omega-N-Methylarginine; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphates; Rats; Rats, Sprague-Dawley; Time Factors | 1996 |